105.90 -0.13 (-0.12%)
Pre-Market: 4:55AM EDT
|Bid||105.83 x 1300|
|Ask||105.90 x 3000|
|Day's Range||105.74 - 107.20|
|52 Week Range||70.73 - 107.20|
|Beta (3Y Monthly)||0.22|
|PE Ratio (TTM)||25.78|
|Earnings Date||Apr 23, 2019|
|Forward Dividend & Yield||2.87 (2.76%)|
|1y Target Est||101.12|
Investors on Tuesday will continue parsing through an onslaught of earnings results in search of signals for the directions of future growth in the corporate world.
FT subscribers can click here to receive FirstFT every day by email. Barclays is cracking down on bankers’ pay as part of a cost-cutting drive to boost returns at Britain’s underperforming, and only remaining, ...
The consumer staples giant has outperformed the sector in 2019, but its stock chart shows extremely overbought technical readings.
Persisting Challenges Could Hurt Colgate-Palmolive in Q1(Continued from Prior Part)Consensus estimateColgate-Palmolive’s (CL) bottom line has stayed low and registered YoY (year-over-year) falls for the past two consecutive quarters despite a
Persisting Challenges Could Hurt Colgate-Palmolive in Q1(Continued from Prior Part)The consensus estimate for the first quarterColgate-Palmolive (CL) has failed to impress with its sales performance in the past several quarters. The company managed
Kimberly-Clark Beats Q1 Estimates on Higher Pricing(Continued from Prior Part)Challenges persist Kimberly-Clark (KMB) stock could benefit from its stronger-than-expected first-quarter results in the near term. Higher pricing, a favorable mix, and
Persisting Challenges Could Hurt Colgate-Palmolive in Q1What to expect Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26. Analysts’ first-quarter estimates indicate that
Kimberly-Clark Beats Q1 Estimates on Higher PricingKey takeaways Kimberly-Clark (KMB) posted stronger-than-expected first-quarter results today. The stock was trading higher in the pre-market session. Kimberly-Clark’s top and bottom line handily
P&G stock is up 15.4% year to date and has risen 44% in the trailing 12-month period, putting it ahead of its consumer staples peers, which have lagged behind the market in recent years.
Yacktman Focused Fund (Trades, Portfolio), the non-diversified investment firm, sold shares of the following stocks during the first quarter. Warning! GuruFocus has detected 2 Warning Sign with TCFC. GuruFocus gives the company a profitability and growth rating of 7 out of 10.
Disruption may be the most overused word in the tech space, but no sector is safe—including staples stocks—as a new breed of consumer takes center stage. Over a decade ago, online travel agents changed the way people booked trips. In 2016 and 2017, retail was in a downward spiral as the ever-growing tide of e-commerce slammed into older, outdated models.
Former Procter & Gamble Co. manager Molly VandenHeuvel has been hired as chief operating officer of Oil-Dri Corp. of America.
Investors looking for reliable dividends should consider the Dividend Aristocrats, a group of 57 stocks in the S&P 500 Index that have increased their dividends for at least 25 consecutive years. There are several consumer staples stocks on the list of Dividend Aristocrats, including Kimberly-Clark Corp. The best consumer staples stocks have strong brands with powerful name recognition.
Procter & Gamble (NYSE:PG) will announce its earnings next Tuesday before the opening bell. Despite the venerable personal-care products maker's reputation as a defensive dividend payer, PG stock has rallied massively over the last year.Source: Mike Mozart via Flickr (Modified)Unfortunately, the rally may have left new investors with less incentive to buy PG stock. With the multiples of PG stock having risen to multi-year highs and its profit growth remaining moderate at best, investors should probably think twice about buying Procter and Gamble at these levels. * 5 Dividend Stocks Perfect for Retirees Expect Slight Earnings, Revenue IncreasesFor PG's fiscal third quarter, analysts' consensus earnings per share estimate is $1.03. That's 3% higher than Q3 of 2018 when the company earned $1 per share of PG stock. Analysts on average predict revenues of $16.32 billion, a slight gain from the $16.28 billion the company generated during last year's Q3.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn the surface, PG appears to be performing well. Trading near its all-time highs, PG stock is 50% above its levels of one year ago. That seems unusual for a stock that traders tend to buy for its dividend.After the company raised the dividend of PG stock this year, the payout has risen for 63 straight years, the fourth-longest streak on Wall Street. PG has paid a dividend every year since 1890. Currently at $2.87 per share, the payout yields 2.75%. Will Investors Continue to Buy PG Stock After the Surge?The impressive rally of PG stock has made it less appealing. The dividend yield of PG stock was about 3.5% this time last year, versus 2.75% now. Moreover, PG's price-earnings (PE) ratio has risen to 25.74. In fairness, Procter & Gamble's peers such as Colgate-Palmolive (NYSE:CL), Kimberly Clark (NYSE:KMB), and Clorox (NYSE:CLX) trade at comparable or higher multiples.Still, the current PE ratio of PG is above its average PE over the last five years of 23.5. It's also well above the mid-teen multiples Procter & Gamble was awarded in the early part of the decade. Also, Wall Street expects PG to report solid, but unimpressive, profit increases. On average, analysts forecast 5.2% profit growth for this fiscal year and 7% next year. Those increases appear too low to justify the current PE ratio of PG stock.Furthermore, even after spinning off numerous brands in the middle part of the decade, PG stock remains vulnerable. For all of its accolades, the competitive moat of Procter and Gamble begins and ends with brand recognition and store-shelf space. Consumers know and love PG's brands such as Tide laundry detergent and Bounty paper towels. However, thanks to e-commerce, consumers can more easily find comparable products at lower prices.I do not think the increased competition will wipe out PG stock. I also do not believe that the rising dividend of PG stock will be threatened. Still, the company may have difficulty growing its revenue, making PG's current valuation difficult to justify. Going into earnings, few investors have an incentive to buy Procter and Gamble at these levels. Final Thoughts on PG StockGiven the recent increases in its price, PG stock will probably struggle to move higher in the near-term. As a result, I see no reason to buy PG 's shares ahead of its earnings.Procter and Gamble enjoyed an unexpected but impressive run over the last year. However, consumer defensive stocks better known for paying dividends rarely have such rallies. Despite increasing competition and analysts' belief that the company's revenue growth was anemic last quarter, I think the stock's dividend will continue to rise. However, other stocks feature annual dividend hikes and lower valuations.For now, income-oriented investors will probably find higher overall returns elsewhere.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Going Into Earnings, Will Procter & Gamble Stock Move Higher? appeared first on InvestorPlace.
What to Expect from Procter & Gamble’s Q3 2019 Results(Continued from Prior Part)Consensus target price indicates downsideThe majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock. The company has impressed
What to Expect from Procter & Gamble’s Q3 2019 Results(Continued from Prior Part)Positive surprise history Procter & Gamble (PG) has a long history of exceeding analysts’ EPS estimates. The company has surpassed Wall Street’s EPS
What to Expect from Procter & Gamble’s Q3 2019 Results(Continued from Prior Part)PG to sustain momentum in organic sales Procter & Gamble (PG) impressed with its underlying sales growth rate in the first half of fiscal 2019. We expect this
What to Expect from Procter & Gamble’s Q3 2019 ResultsPG is expected to sustain momentum Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.
U.S. stock futures are climbing in early morning trading.Source: Shutterstock Ahead of the bell, futures on the Dow Jones Industrial Average are up 0.19%, and S&P 500 futures are higher by 0.27%. Nasdaq-100 futures have added 0.52%.With record highs a stone's throw away, bullish option flows continue to suggest a retest is on the horizon. In the options pits, call activity surged yesterday, pushing overall volume back above average readings. Specifically, about 20.2 million calls and 14.8 million puts changed hands on the session.InvestorPlace - Stock Market News, Stock Advice & Trading TipsMeanwhile, the action at the CBOE mirrored that of the previous day with the single-session equity put/call volume holding steady at 0.58. The 10-day moving average remains at 0.59.Options traders flocked to the following three stocks: Proctor & Gamble (NYSE:PG), UnitedHealth Group (NYSE:UNH) and Qualcomm (NASDAQ:QCOM).Let's dig into the details: Proctor & Gamble (PG)The drumbeat of new highs continued for Proctor & Gamble on Tuesday. With the day's gains, the consumer staples stock pushed its year-to-date gains to 15.9%. Chart watchers continue to salivate over the consistency of its uptrend. The series of higher highs and lows has been relentless in 2019, and all major moving averages are rising beneath. * 10 S&P 500 Stocks to Weather the Earnings Storm Despite the substantial rise, PG stock still boasts a meaty dividend at 2.82%, and it is the allure of cash flow that landed the company atop yesterday's leaderboard. Traders harnessed the power of call options for short-term control of PG stock ahead of Wednesday's ex-dividend date. Its next quarterly dividend payment of 74.6 cents will be paid to shareholders.As is usually the case ahead of dividend dates, options traders went cuckoo for call options.On the options trading front, traders came after calls with a vengeance. Activity exploded to 1,232% of the average daily volume, with 204,899 total contracts traded; 85% of the trading came from call options alone.Implied volatility drifted sideways on the session at 20%, which places it at the 40th percentile of its one-year range. Premiums are baking in daily moves of $1.37 or 1.3%. UnitedHealth Group (UNH)Traders played whack-a-mole with UNH stock after the healthcare company reported first-quarter earnings that surpassed expectations. UnitedHealth raked in $3.60 of earnings-per-share on revenue of $60.31 billion. Both metrics topped analyst forecasts.And yet, the early morning gains melted as the recent proposals for "Medicare-for-all" by some Democrats running for president took root. Here's the money quote from CEO David Wichmann during the company's conference call: "The wholesale disruption of American health care would surely jeopardize the relationship people have with their doctors, destabilize the nation's health system, and limit the ability of clinicians to practice medicine at their best."UNH stock ended down 4.12% on the session, falling to a new 52-week low.On the options trading front, calls ruled the roost despite the early-morning rug pull. Activity grew to 881% of the average daily volume, with 160,336 total contracts traded. Calls claimed 65% of the total.The typical "volatility crush" in implied volatility following earnings was held at bay by the high uncertainty that came out of the conference call. Implied volatility remains sky high at 34% or the 73rd percentile of its one-year range. Traders continue to expect daily moves of $4.69 or 2.1%. Qualcomm (QCOM)An unexpected settlement to Qualcomm's multi-year legal battle with Apple (NASDAQ:AAPL) was announced yesterday, and the chipmaker is zooming to the moon. When the news hit the wires, QCOM stock rocketed 20% higher. The buying has continued unabated in after-hours trading, and QCOM is up another 12%. That means it will open at a new four-and-a-half year high. * 7 Stocks to Buy for Spring Season Growth The only resistance level that remains between Qualcomm and new record highs is the 2014 peak of $81.97. And with the rapid repricing going on over the past 24 hours, the stock could get there in a hurry.As you might expect, calls dominated the day by a large margin. Total activity climbed to 492% of the average daily volume, with 361,393 contracts traded; 80% of the day's take fell on the call side of the ledger.Implied volatility dropped to 34% placing it at the 56th percentile of its one-year range. Premiums are pricing in daily moves of $1.52 or 2.2%As of this writing, Tyler Craig didn't hold a position in any of the aforementioned securities. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy for Spring Season Growth * This Is How You Beat Back a Bear Market * 7 Dental Stocks to Buy That Will Make You Smile Compare Brokers The post Wednesday's Vital Data: Proctor & Gamble, UnitedHealth Group and Qualcomm appeared first on InvestorPlace.
Investors need to pay close attention to Procter & Gamble (PG) stock based on the movements in the options market lately.